PYCR1 and lung adenocarcinoma: In the current study, we show that genetic ablation of kindlin-2 is sufficient to inhibit the increases of the levels of PYCR1, proline, and collagen matrix in lung adenocarcinoma and reduces tumor burden and mortality rate in vivo (Fig. 9, 10).